[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341829-105":59,"doc-detail-341829-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","acyp2-functions-as-an-innovative-nano-therapeutic-target-to-impede-the-progression-of-hepatocellular-carcinoma-by-inhibiting-the-activity-of-tert-and-the-kcnn4erk-pathway","ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway","","An evidence base links acylphosphatase-2 (ACYP2) polymorphisms to higher cancer susceptibility, yet ACYP2’s roles and mechanisms in hepatocellular carcinoma remain unclear. ACYP2 is found downregulated in HCC and inversely associated with tumor size, differentiation, microvascular invasion, and patient prognosis. ACYP2 overexpression suppresses proliferation and metastasis while promoting apoptosis, whereas knockdown reverses these effects. Mechanistically, cytoplasmic ACYP2 downregulates KCNN4, blocks K+ outflow, and inactivates ERK; nuclear ACYP2 inhibits TERT activity, shortens telomeres, and reverses immortalization. A targeted nanotherapy using pcDNA-ACYP2 in polyetherimide nanoparticles coated with HCC membranes shows safety and tumor-targeting, impeding TERT activity and the KCNN4/ERK pathway in models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/acyp2-functions-as-an-innovative-nano-therapeutic-target-to-impede-the-progression-of-hepatocellular-carcinoma-by-inhibiting-the-activity-of-tert-and-the-kcnn4erk-pathway/341829/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/acyp2-functions-as-an-innovative-nano-therapeutic-target-to-impede-the-progression-of-hepatocellular-carcinoma-by-inhibiting-the-activity-of-tert-and-the-kcnn4erk-pathway/341829.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the relationship between ACYP2 expression and hepatocellular carcinoma progression?","Question",{"text":112,"@type":113},"ACYP2 is lowly expressed in HCC and negatively correlates with tumor size, differentiation, microvascular invasion, and prognosis, indicating an inhibitory role in disease progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does cytoplasmic ACYP2 affect the KCNN4/ERK pathway?",{"text":117,"@type":113},"Cytoplasmic ACYP2 negatively regulates KCNN4, leading to inhibited K+ outflow and subsequent inactivation of the ERK pathway, which reduces HCC growth and metastasis.",{"name":119,"@type":110,"acceptedAnswer":120},"How does nuclear ACYP2 influence telomerase and telomere length?",{"text":121,"@type":113},"Nuclear ACYP2 inhibits telomerase reverse transcriptase (TERT) activity, resulting in reduced telomere length and reversal of HCC cell immortalization.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341829,1790121019,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Wu et al. Journal of Nanobiotechnology (2024) 22:557  \n[https://doi.org/10.1186/s12951-024-02827-4](https://doi.org/10.1186/s12951-024-02827-4)  \nJournal of Nanobiotechnology  \n RESEARCH Open Access  \nACYP2 functions as an innovative  \nnano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway  \nYixuan Wu1,2†, Hongyi Bao1,2†, Jinran Wu1,2†, Bairong Chen1,2, Jing Xu1,2, Kangfeng Jin1,2, Lin Chen3*, Guang Zhu4* and Feng Wang1,2*  \nAbstract  \nAn increasing body of evidence suggests that acylphosphatase-2 (ACYP2) polymorphisms are correlated  \nwith an increased susceptibility to a range of malignancies. Nevertheless, its potential functions, molecular mechanisms in hepatocellular carcinoma (HCC) and whether it can be act as a therapeutic target remain uninvestigated. Herein, ACYP2 was found to be lowly expressed in HCC and was negatively correlated with tumor size, tumor differentiation, microvascular invasion and the prognosis of HCC patients. Functional investigations revealed that overexpression of ACYP2 inhibited the proliferation and metastasis of HCC cells while promoting apoptosis; knockdown of ACYP2 had the exact opposite effect. Additionally, it was observed that ACYP2 was distributed in both the cytoplasm and nucleus of HCC cells. According to the mechanistic studies, the expression of potassium calcium-activated channel subfamily N member 4 (KCNN4) was negatively regulated by cytoplasmic ACYP2, resulting in the inhibition of K+ outflow and subsequent inactivation of the ERK pathway, which impeded the growth and metastasis of HCC. Furthermore, the activity of telomerase reverse transcriptase (TERT) was inhibited by nuclear ACYP2, leading to the reduction in length of telomeres and consequent reversal of HCC cell immortalization. Additionally, a novel targeted nanotherapy strategy was developed wherein the pcDNA-ACYP2 vector was encapsulated within polyetherimide nanoparticles (PEI/NPs), which were subsequently coated with HCC cell membranes (namely pcDNA/PEI/NPs@M) . Safety and targeting characteristics abound for these nanocomposites, in both subcutaneous graft tumor models and orthotopic mouse models, they inhibited the progression of HCC by impeding TERT activity and the KCNN4/ERK pathway. In conclusion, our research identifies novel molecular mechanisms involving cytoplasmic and nuclear ACYP2 that inhibit the progression of HCC. Moreover, pcDNA/PEI/NPs@M represents a targeted therapeutic strategy for HCC that holds great promising.  \n†Yixuan Wu, Hongyi Bao and Jinran Wu contributed equally to this work.  \n*Correspondence: Lin Chen [xiaobei227@sina.com](xiaobei227@sina.com)[ ](xiaobei227@sina.com)Guang Zhu [gzhu@ust.hk](gzhu@ust.hk)  \nFeng Wang [richardwangf@163.com](richardwangf@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[","cbCaitpypRXfagO7","https://ap.wps.com/l/cbCaitpypRXfagO7","pdf",5064907,22,"English","# Abstract\n## Introduction\n## Acylphosphatase-2 (ACYP2) background\n## ACYP2 polymorphisms and cancer susceptibility","[{\"question\":\"What is the relationship between ACYP2 expression and hepatocellular carcinoma progression?\",\"answer\":\"ACYP2 is lowly expressed in HCC and negatively correlates with tumor size, differentiation, microvascular invasion, and prognosis, indicating an inhibitory role in disease progression.\"},{\"question\":\"How does cytoplasmic ACYP2 affect the KCNN4/ERK pathway?\",\"answer\":\"Cytoplasmic ACYP2 negatively regulates KCNN4, leading to inhibited K+ outflow and subsequent inactivation of the ERK pathway, which reduces HCC growth and metastasis.\"},{\"question\":\"How does nuclear ACYP2 influence telomerase and telomere length?\",\"answer\":\"Nuclear ACYP2 inhibits telomerase reverse transcriptase (TERT) activity, resulting in reduced telomere length and reversal of HCC cell immortalization.\"}]","ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway | PDF",1790044042,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fb6d23d33c4a3b1e88ba25c256ab009.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f31944aee6fbe1f4773b8c7056926755.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8642a266aa667172cd48446279901be3.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1c458e5729e248abe4408f91f32143c.webp",980,1301]